SEC Form 4 · accession 0001554795-15-000507
IRIS BIOTECHNOLOGIES INC · IRSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Dec 15, 2015
Accepted (ET)
Dec 30, 2015 · 10:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 15, 2015 | P | 100 | $0.2249 | A | 10,027,521 | D | |
| Common Stock | Dec 15, 2015 | P | 100 | $0.19 | A | 10,027,621 | D | |
| Common Stock | Dec 29, 2015 | J | 1,388,889 | $0.06 | A | 11,416,510 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
$83,333.34 in salary paid in stock.